Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,785 | 23,571 | 6,849 | 8,142 | 4,517 |
| Receivables | 35,347 | 18,953 | 12,664 | 11,010 | 26,901 |
| Inventories | 23,108 | 23,826 | 25,266 | 25,904 | 27,408 |
| Income taxes - deferred | 683 | 375 | 403 | 364 | 344 |
| Other current assets | 9,750 | 0 | 1,047 | 0 | 0 |
| TOTAL | $120,862 | $107,142 | $88,378 | $88,615 | $88,624 |
| Non-Current Assets | |||||
| PPE Net | 29,614 | 29,984 | 30,418 | 28,269 | 28,573 |
| Intangibles | 5,013 | 5,075 | 5,131 | 5,237 | 5,277 |
| Other Non-Current Assets | 16,120 | 14,365 | 11,063 | 14,102 | 13,911 |
| TOTAL | $50,747 | $49,423 | $46,612 | $47,608 | $47,761 |
| Total Assets | $171,609 | $156,565 | $134,990 | $136,223 | $136,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,175 | 19,175 | 5,681 | 10,641 | 10,595 |
| Accounts payable and accrued liabilities | 16,357 | 13,627 | 11,167 | 9,771 | 9,488 |
| Other current liabilities | 4,809 | 5,223 | 3,954 | 3,301 | 3,331 |
| TOTAL | $48,308 | $42,267 | $23,655 | $25,028 | $28,388 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 79 | 0 | 206 |
| TOTAL | $796 | $796 | $874 | $802 | $1,005 |
| Total Liabilities | $49,104 | $43,063 | $24,529 | $25,831 | $29,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,697 | 8,396 | 7,605 | 7,605 | 7,605 |
| Common Shares | 9 | 8 | 8 | 8 | 8 |
| Retained earnings | 69,639 | 64,729 | 61,918 | 60,943 | 58,610 |
| Other shareholders' equity | 10,974 | 10,979 | 10,844 | 11,811 | 11,350 |
| TOTAL | $122,505 | $113,502 | $110,461 | $110,393 | $106,992 |
| Total Liabilities And Equity | $171,609 | $156,565 | $134,990 | $136,224 | $136,385 |